Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
A8724 ONC201Summary: activates p53-independent apoptosis -
A8188 Atractyloside Dipotassium Salt1 CitationTarget: AATSummary: AAT inhibitor -
A8567 Tenovin-3Summary: p53 activator -
A9901 Caspase Inhibitor Set ISummary: Caspase Inhibitors -
B4902 (+)-ApogossypolTarget: Bcl-2Summary: inhibitor of Bcl-2 family proteins -
A8176 Apicidin2 CitationTarget: Histone Deacetylases (HDACs)Summary: Potent HDAC inhibitor -
A4456 PlumbaginSummary: Anticancer agent -
A4487 WR 1065Summary: P53/p21waf-1/MDM2 activator -
A8955 Z-YVAD-FMK7 CitationTarget: CaspasesSummary: Caspase-1 inhibitor -
B4881 UMI-771 CitationTarget: Mcl-1Summary: Mcl-1 inhibitor, novel

